表紙
市場調査レポート

中国のPTCAバルーン市場の投資分析

China PTCA Balloon Market Investment Report, 2014-2016

発行 ResearchInChina 商品コード 312751
出版日 ページ情報 英文 114 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
中国のPTCAバルーン市場の投資分析 China PTCA Balloon Market Investment Report, 2014-2016
出版日: 2014年09月12日 ページ情報: 英文 114 Pages
概要

生活水準の上昇に伴い、中国でも経皮的冠動脈インターベンション(PCI)を受ける患者数が増加しています。2013年のPCIの症例数は454,505件(前年比16.9%増)となり、またPTCAバルーンの需要量も118万6000セット(同13.8%増)に達しました。それでも人口100万人当たりの処置件数は309.42件と、米国(同1800件)などと比べて、対人口普及率はまだはるかに低い状態となっています。逆に、その状態が今後の中国市場の成長機会をもたらしている、とも言えます。現段階では外資系企業が市場を支配していますが、中国系企業も競争力を次第に高めており、2009年には合計20%だった市場シェアが、2013年には約40%にまで拡大しています。

当レポートでは、中国におけるPTCA(経皮経管冠動脈形成術)バルーン市場の概況と今後の投資機会について分析し、操業・経営環境(マクロ経済動向、政府の政策、医療水準など)や、市場の最新動向・需給バランス、企業間競争の状態、今後の市場成長の見通し、中国市場への投資のメリット/デメリットや収益性、国内系・外資系企業のプロファイルといった情報をお届けいたします。

第1章 PTCAバルーン産業に関する諸概念

  • PTCA(経皮経管冠動脈形成術)バルーンの定義と分類
  • 侵襲性医療機器の定義と分類

第2章 中国のPTCAバルーン市場の操業環境

  • マクロ環境
  • 政策動向
  • 医療・衛生水準
  • 中国の医療機器産業の現状

第3章 中国のPTCAバルーン市場の概況

  • 現状
  • 発展のボトルネック
  • 需給状況
    • 需要量
    • 供給量
  • 競争環境
  • 発展の見通しと将来予測

第4章 中国のPTCAバルーン市場への投資

  • 好ましい要素
    • 政府の産業政策による強力な支援
    • 財政面でのインセンティブ
    • 市場需要の拡大
    • 市場の急速な標準化
  • 好ましくない要素
    • 価格低下リスクの増大
    • 関連する生産材料・装置の不足
    • 諸外国の非関税障壁
  • 経済的利点
  • 工場の立地選択
    • 成都
    • 杭州
  • GMP(優良医薬品製造基準)工場の建設

第5章 主な国内系企業

  • Lepu Medical
    • プロファイル
    • 経営概況
    • 収益構造
    • 粗利益率
    • PTCAバルーン事業
    • 研究開発(R&D)および投資額
    • 将来予測と今後の見通し
  • MicroPort
  • JW Medical
  • Dalian Yinyi
  • Neich Medical (Shenzhen)
  • SCW Medicath
  • Synexmed
  • Sino Medical
  • Demax Medical (Beijing)

第6章 主な外資系企業

  • Medtronic
    • プロファイル
    • 経営概況
    • PTCAバルーン事業
    • 中国国内での事業展開
  • Boston Scientific
  • Abbott
  • テルモ
  • B. Braun Melsungen

図表一覧

目次
Product Code: ZLC008

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. Therefore, the development of PTCA balloon industry is closely related to that of PCI.

As national economy develops and people's living standard improves, the number of patients receiving PCI has been on the rise year by year, and totaled 454,505 cases in China in 2013, up 16.9% from a year earlier. Demand for PTCA balloon during the same period reached 1.186 million sets, rising by 13.8% on a year-on-year basis.

Despite year-on-year growth in the number of PCI cases in China, the penetration is still very low. In 2013, 309.42 per 1 million were people receiving PCI treatment in China, compared with 1800 cases in the United States, showing a vast space for development of the Chinese PCI market and a bright future for PTCA balloon industry. It is expected that China's demand for PTCA balloon will hit 1.824 million sets by 2016.

At present, the Chinese PTCA balloon market is still dominated by foreign companies, such as Medtronic, Abbott, Boston Scientific, Goodman, Terumo, etc. However, local Chinese PTCA balloon companies are improving their competitiveness, with overall market share rising to about 40% in 2013 as opposed to 20% in 2009.

Local Chinese PTCA balloon companies include Lepu Medical, MicroPort, JW Medical, Yinyi, Neich Medical (Shenzhen), Synexmed, Sino Medical and Demax Medical, of which Lepu Medical, MicroPort, Neich Medical (Shenzhen) and Sino Medical manufacture both PTCA balloon catheter for delivering coronary stent and PTCA balloon, JW Medical manufactures only PTCA balloon for delivering coronary stent, and Demax Medical produces only PTCA balloon.

MicroPort is a bellwether in the Chinese coronary stent system market. On Jan. 20, 2014, MicroPort announced that it would acquire drug-eluting stent-related assets of Cordis under Johnson & Johnson. After the acquisition is completed, MicroPort's share in drug-eluting stent market will rise by over 10%. This will also promote company's business development of PTCA balloon for delivering coronary stent. MicroPort now can manufacture more than 200,000 sets of PTCA balloon annually.

Lepu Medical is a leading player in China PTCA balloon industry. The company now has PTCA balloon dilatation catheter capacity of 100,000 sets and coronary stent delivery system capacity of 170,000 sets.

Demand of PTCA Ballon in China, 2012 Vs 2013

                     Source: China PTCA Balloon Market Investment Report, 2014-2016 by ResearchInChina.

China PTCA Balloon Catheter Market Investment Report, 2014-2016 focuses on the following:

  • Operating environment of the Chinese PTCA balloon market, including macro environment, policy climate, medical & health care level and status quo of China medical device industry;
  • Overview of the Chinese PTCA balloon market, covering status quo, development bottlenecks, supply & demand, competitive landscape and development outlook and forecast;
  • Investment in the Chinese PTCA balloon market, including favorable and unfavorable factors, economic benefit and site selection of plants;
  • Operation and PTCA balloon business of 5 foreign and 9 Chinese PTCA balloon companies.

Table of Contents

1. Concepts Related to PTCA Balloon Industry

  • 1.1. Definition and Classification of PTCA Balloon
  • 1.2. Definition and Classification of Interventional Medical Device

2. Operating Environment of Chinese PTCA Balloon Market

  • 2.1. Macro Environment
  • 2.2. Policy Climate
  • 2.3. Medical & Health Care Level
  • 2.4. Status Quo of China Medical Device Industry

3. Overview of Chinese PTCA Balloon Market

  • 3.1. Status Quo
  • 3.2. Development Bottleneck
  • 3.3. Supply & Demand
    • 3.3.1. Demand
    • 3.3.2. Supply
  • 3.4. Competitive Landscape
  • 3.5. Development Outlook and Forecast

4. Investment in Chinese PTCA Balloon Market

  • 4.1. Favorable Factors
    • 4.1.1. Strong Support by National Industrial Policy
    • 4.1.2. Financial Incentives
    • 4.1.3. Expanding Market Demand
    • 4.1.4. Increasingly Standardized Market
  • 4.2. Unfavorable Factors
    • 4.2.1. Mounting Risk of Price Drop
    • 4.2.2. Shortage of Related Production Materials and Equipment
    • 4.2.3. Foreign Non-Tariff Barriers
  • 4.3. Economic Benefit
  • 4.4. Site Selection of Plants
    • 4.4.1. Chengdu
    • 4.4.2. Hangzhou
  • 4.5. Construction of GMP Plant

5. Major Chinese Companies

  • 5.1. Lepu Medical
    • 5.1.1. Profile
    • 5.1.2. Operation
    • 5.1.3. Revenue Structure
    • 5.1.4. Gross Margin
    • 5.1.5. PTCA Balloon Business
    • 5.1.6. R&D and Investment
    • 5.1.7. Forecast and Outlook
  • 5.2. MicroPort
    • 5.2.1. Profile
    • 5.2.2. Operation
    • 5.2.3. Revenue Structure
    • 5.2.4. PTCA Balloon Business
    • 5.2.5. R&D and Investment
    • 5.2.6. Forecast and Outlook
  • 5.3. JW Medical
    • 5.3.1. Profile
    • 5.3.2. PTCA Balloon Business
  • 5.4. Dalian Yinyi
    • 5.4.1. Profile
    • 5.4.2. PTCA Balloon Business
  • 5.5. Neich Medical (Shenzhen)
    • 5.5.1. Profile
    • 5.5.2. PTCA Balloon Business
  • 5.6. SCW Medicath
    • 5.6.1. Profile
    • 5.6.2. PTCA Balloon Business
  • 5.7. Synexmed
    • 5.7.1. Profile
    • 5.7.2. PTCA Balloon Business
  • 5.8. Sino Medical
    • 5.8.1. Profile
    • 5.8.2. PTCA Balloon Business
  • 5.9. Demax Medical (Beijing)
    • 5.9.1. Profile
    • 5.9.2. PTCA Balloon Business

6. Major Foreign Companies

  • 6.1. Medtronic
    • 6.1.1. Profile
    • 6.1.2. Operation
    • 6.1.3. PTCA Balloon Business
    • 6.1.4. Operation in China
  • 6.2. Boston Scientific
    • 6.2.1. Profile
    • 6.2.2. Operation
    • 6.2.3. PTCA Balloon Business
    • 6.2.4. Operation in China
  • 6.3. Abbott
    • 6.3.1. Profile
    • 6.3.2. Operation
    • 6.3.3. PTCA Balloon Business
    • 6.3.4. Operation in China
  • 6.4. Terumo
    • 6.4.1. Profile
    • 6.4.2. Operation
    • 6.4.3. PTCA Balloon Business
    • 6.4.4. Operation in China
  • 6.5. B. Braun Melsungen
    • 6.5.1. Profile
    • 6.5.2. Operation
    • 6.5.3. PTCA Balloon Business
    • 6.5.4. Operation in China

Selected Charts:

  • Main Devices Used for PCI
  • OTW Balloon Catheter Diagram
  • Monorail/Rapid Exchange Balloon Catheter Diagram
  • Classification of Interventional Medical Device
  • China's GDP and YoY Growth Rate, 1985-2013
  • Health Costs and % of GDP in China, 1980-2013
  • Per Capita Health Costs and YoY Growth Rate in China, 2006-2013E
  • Number of People 65 and Over and % of Total Population in China, 2004-2013
  • Laws and Regulations about Medical Device Industry in China
  • Industry Policies Concerning PTCA Balloon Industry
  • Number of Medical Institutions and Sickbeds in China, 2012-2013
  • Medical Service Quantity of Health Care Facilities in China, 2012-2013
  • Usage of Sickbeds in China's Medical Institutions, 2012-2013
  • Total Industrial Output Value and YoY Growth Rate of China Medical Device Industry, 2005-2013E
  • Sales and YoY Growth Rate of China Medical Device Industry, 2005-2013E
  • Market Share of Home-made Coronary Drug-eluting Stent System in China, 2009-2013
  • Number of PCI Cases and Growth Rate in China, 2011-2013
  • Coronary Stent Implantation and Usage Percentage of Drug-eluting Stent in China, 2011-2013
  • China's Demand for PTCA Balloon, 2011-2013
  • Major Coronary Stent System Brands and Their Market Shares in China (by Consumption), 2013
  • Market Share Comparison between Home-made and Imported PTCA Balloon, 2013
  • Number of PCI Cases and Growth Rate in China, 2011-2016E
  • Local Regulations on Circulation and Usage of Interventional Medical Devices
  • Market Prices of Major PTCA Balloon Catheter Brands in China, 2008/2013E
  • Operating Revenue and Total Profit of Artificial Limb, Artificial Organ and Interventional Medical Device Manufacturing, 2009-2014
  • Chengdu's GDP and YoY Growth Rate, 2009-2013
  • Chengdu's GDP and Percentage by Industry, 2013
  • Chengdu's Total Fixed Asset Investment and YoY Growth, 2009-2013
  • Chengdu's Total Fixed Asset Investment Breakdown by Industry, 2013
  • Actual Use of Foreign Direct Investment and YoY Growth in Chengdu, 2009-2013
  • Chengdu's Total Industrial Output Value and YoY Growth, 2009-2013
  • Chengdu's Industrial Value Added and YoY Growth, 2009-2013
  • Chengdu's Industrial Value Added by Sector and Percentage, 2013
  • Average Wage of Employees in Chengdu, 2009-2013
  • List of Industrial Parks in Chengdu
  • Unit Price of Electricity in Chengdu Hi-Tech Industrial Development Zone
  • Unit Price of Water in Chengdu Hi-Tech Industrial Development Zone
  • Unit Price of Gas in Chengdu Hi-Tech Industrial Development Zone
  • International Air Transport Price Comparison between Chengdu and Shanghai & Hong Kong
  • International Air Transport Incidentals Comparison between Chengdu and Shanghai
  • List of Time and Prices for Railway Transportation from Chengdu to Shanghai/Shenzhen
  • Hangzhou's GDP and YoY Growth, 2005-2013
  • Hangzhou's Total Industrial Output Value and YoY Growth, 2005-2012
  • Hangzhou's Total Fixed Asset Investment and YoY Growth, 2005-2013
  • Average Wage of On-post Employees in Hangzhou, 2009-2013
  • List of Development Zones in Hangzhou
  • Main Preferential Policies in Export Processing Zone of Hangzhou Economic and Technological Development Zone Compared with Other Regions
  • Unit Price of Electricity in Hangzhou Economic and Technological Development Zone
  • Unit Price of Water in Hangzhou Economic and Technological Development Zone
  • Unit Price of Gas in Hangzhou Economic and Technological Development Zone
  • Cost Estimation for 100,000-grade Clean Workshop in China
  • Distribution of Lepu Medical's Subsidiaries
  • Revenue, Net Income and Gross Margin of Lepu Medical, 2009-2013
  • Revenue Breakdown of Lepu Medical (by Product), 2009-2013
  • Revenue Breakdown of Lepu Medical (by Region), 2009-2013
  • Gross Margin of Lepu Medical (by Product), 2009-2013
  • Technical Parameters of Lepu Medical's Hoper PTCA Balloon Dilatation Catheter
  • Models and Parameters of Lepu Medical's GRIP High Pressure Papillary Balloon Dilatation Catheter
  • Balloon Compliance of Lepu Medical's Nano plus and Partner Stent Delivery System
  • Specifications of Lepu Medical's Biguard Stent System
  • Balloon Compliance of Lepu Medical's Biguard Stent Delivery System
  • Balloon Compliance of Lepu Medical's GuReater Stent Delivery System
  • R&D Costs and % of Total Revenue of Lepu Medical, 2010-2013
  • Projects with Funds from IPO or Refinancing and Completion Status of Lepu Medical
  • Revenue and Net Income of Lepu Medical, 2012-2016E
  • Revenue, Net Income and Gross Margin of MicroPort, 2009-2013
  • Revenue Breakdown of MicroPort (by Product), 2011-2013
  • Revenue Structure of MicroPort (by Product), 2011-2013
  • Revenue Breakdown of MicroPort (by Region), 2009-2013
  • Revenue Structure of MicroPort (by Region), 2009-2013
  • Revenue from Cardiovascular Interventional Products and % of Total Revenue of MicroPort, 2011-2013
  • Specifications of MicroPort's Pioneer Balloon Dilatation Catheter
  • Specifications of MicroPort's Hercules Balloon Dilatation Catheter
  • R&D Costs and % of Total Revenue of MicroPort, 2009-2013
  • Revenue and Net Income of MicroPort, 2012-2016E
  • Balloon Compliance of JW Medical's EXCEL Drug-eluting Stent Delivery System
  • Features of Dalian Yinyi's Balloon Dilatation Catheters
  • Balloon Compliance of Dalian Yinyi's Pre-dilatation Balloon Catheter Series
  • Balloon Compliance of Dalian Yinyi's Post-dilatation Balloon Catheter Series
  • Specifications and Models of Dalian Yinyi's Balloon Dilatation Catheters
  • Compliance of Neich Medical (Shenzhen)'s Sapphire II Balloon Dilatation Catheter
  • Compliance of Neich Medical (Shenzhen)'s PCTA Balloon Dilatation Catheter
  • Compliance of Neich Medical (Shenzhen)'s Sapphire NC High Pressure Balloon Dilatation Catheter
  • Compliance of Neich Medical (Shenzhen)'s Scoreflex Dual-wire Balloon Dilatation Catheter
  • SCW Medicath's PTCA Balloon Dilatation Catheters
  • Features and Advantages of SCW Medicath's PTCA Balloon Dilatation Catheters
  • Technical Parameters of SCW Medicath's PTCA Balloon Dilatation Catheters
  • Common Specifications and Models of SCW Medicath's PTCA Balloon Dilatation Catheters
  • Compliance of SCW Medicath's Standard Balloons
  • Compliance of SCW Medicath's High Pressure Balloons
  • Main Technical Parameters of Synexmed's Advancer PTCA Balloon Catheter
  • Compliance of Synexmed's Advancer PTCA Balloon Catheter
  • Main Technical Parameters of Synexmed's Advancer Plus PTCA/CTO Balloon Catheter
  • Balloon Compliance of Synexmed's Advancer Plus PTCA/CTO Balloon Catheter
  • Main Technical Parameters of Synexmed's Advancer Hp High Pressure Balloon Catheter
  • Balloon Compliance of Synexmed's Advancer Hp High Pressure Balloon Catheter
  • Balloon Compliance of Sino Medical's BuMA Delivery System
  • Specifications and Models of Sino Medical's Sleek PTCA Rapid Exchange Dilatation Balloon
  • Balloon Compliance of Sino Medical's Sleek PTCA Rapid Exchange Dilatation Balloon Catheter
  • Diagram for Balloon Passing External Diameter of Sino Medical's Sleek PTCA Rapid Exchange Dilatation Balloon Catheter
  • Technical Parameters of Demax Medical's Gusta PTCA Balloon Dilatation Catheter
  • Specifications and Models of Demax Medical's Gusta PTCA Balloon Dilatation Catheter
  • Balloon Compliance of Demax Medical's Gusta PTCA Balloon Dilatation Catheter
  • Technical Parameters of Demax Medical's Gusta NC Noncompliant Balloon Dilatation Catheter
  • Specifications and Models of Demax Medical's Gusta NC Noncompliant Balloon Dilatation Catheters
  • Balloon Compliance of Demax Medical's Gusta NC Noncompliant Balloon Dilatation Catheters
  • Revenue and Net Income of Medtronic, FY2009-FY2013
  • Revenue Breakdown of Medtronic (by Product), FY2009-FY2013
  • Revenue Structure of Medtronic (by Product), FY2009-FY2013
  • Revenue from Coronary Products and % of Total Revenue of Medtronic, FY2009-FY2013
  • Specifications of Medtronic's Sprinter Legend Semicompliant Balloon
  • Specifications of Medtronic's Sprinter OTW Semicompliant Balloon
  • Specifications of Medtronic's NC Sprinter Rapid Exchange Noncompliant Balloon
  • Specifications of Medtronic's Sprinter Legend OTW Semicompliant Balloon
  • Revenue, Net Income and Gross Margin of Boston Scientific, 2009-2013
  • Revenue Breakdown of Boston Scientific (by Division), 2009-2013
  • Revenue Breakdown of Boston Scientific (by Region), 2009-2013
  • Revenue from Cardiovascular Division and YoY Growth of Boston Scientific, 2009-2013
  • Classification, Performance and Application of Boston Scientific's PTCA Balloon
  • Revenue, Net Income and Gross Margin of Abbott, 2009-2013
  • Revenue Breakdown of Abbott (by Product), 2009-2013
  • Revenue Structure of Abbott (by Product), 2009-2013
  • Revenue from Cardiovascular Products and % of Total Revenue, 2009-2013
  • Models and Specifications of Abbott's TREK&MINI TREK Balloon
  • Models and Specifications of Abbott's NC TREK Balloon
  • Revenue and Net Income of Terumo, FY2010-FY2013
  • Revenue Breakdown of Terumo (by Business), FY2010-FY2013
  • Revenue Breakdown of Terumo (by Region), FY2010-FY2013
  • R&D Costs and % of Total Revenue of Terumo, FY2010-FY2013
  • Revenue from Cardiovascular Business and % of Total Revenue of Terumo, FY2010-FY2013
  • PTCA Balloon Output and YoY Growth of Terumo, FY2009-FY2013E
  • Terumo's Branch Companies in China and Their Main Businesses
  • Terumo's Presence in China
  • Revenue, Net Income and Gross Margin of B. Braun Melsungen, 2009-2013
  • Revenue Breakdown of B. Braun Melsungen (by Division), 2009-2013
  • Revenue Breakdown of B. Braun Melsungen (by Region), 2009-2013
  • Models and Serial Numbers of B. Braun Melsungen's SeQuent Please PTCA Balloon
  • Models and Serial Numbers of B. Braun Melsungen's SeQuent Neo PTCA Balloon
Back to Top